Compounds > glucose, (beta-d)-isomer
Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Cardiac Toxicity

glucose, (beta-d)-isomer has been researched along with Cardiac Toxicity in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (28.57)24.3611
2020's10 (71.43)2.80

Authors

AuthorsStudies
Chang, WT; Chen, ZC; Hong, CS; Kan, WC; Lin, TH; Lin, YW; Shih, JY1
Chi, J; Guo, H; Huang, X; Pan, M; Sun, J; Sun, S; Weng, J; Yang, Q; Zhang, H; Zhou, J1
Chan, SH; Cheng, HC; Chou, WC; Chu, PM; Hsieh, PL; Huang, YT; Tsai, KL1
Amorosi, A; De Rosa, S; Iaconetti, C; Indolfi, C; Mignogna, C; Polimeni, A; Sabatino, J; Sorrentino, S; Spaccarotella, C; Tammè, L; Yasuda, M1
Gao, X; Li, R; Liu, R; Shi, H; Yan, F; Zhuang, X1
Berretta, M; Bonelli, A; Botti, G; Caronna, A; Cocco, S; Conforti, G; De Laurentiis, M; Lombari, MC; Maurea, N; Quagliariello, V; Rea, G1
Chang, WT; Chen, ZC; Ho, CH; Lin, YW; Liu, PY; Shih, JY1
Barış, VÖ; Dinçsoy, AB; Erdem, A; Gedikli, E; Müftüoğlu, S; Zırh, S1
Altucci, L; Barbieri, A; Botti, G; Canale, ML; Carbone, A; Conte, M; De Laurentiis, M; Maurea, N; Monti, MG; Paccone, A; Quagliariello, V; Rea, D1
Gong, X; Huang, J; Lei, S; Lei, Y1
Calvenzani, V; Fornari, M; Giorgio, M; Marinelli, A; Matros, A; Micheli, LA; Mock, HP; Petroni, K; Pilu, R; Tonelli, C; Trinei, M1
Broedl, UC; Hantel, S; Kim, G; Salsali, A; Woerle, HJ1
Cui, XH; Gao, JP; Wang, HL; Wu, R; Xu, X; Yu, HL1
Turner, JR1

Reviews

2 review(s) available for glucose, (beta-d)-isomer and Cardiac Toxicity

ArticleYear
Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta-analysis of data from randomized placebo-controlled trials.
    Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:10

    Topics: Aged; Benzhydryl Compounds; Cardiotoxicity; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Risk Factors

2016
Integrated cardiovascular safety: multifaceted considerations in drug development and therapeutic use.
    Expert opinion on drug safety, 2017, Volume: 16, Issue:4

    Topics: Adult; Animals; Antineoplastic Agents; Benzhydryl Compounds; Blood Pressure; Cardiotoxicity; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Design; Glucosides; Humans; Hypoglycemic Agents

2017

Other Studies

12 other study(ies) available for glucose, (beta-d)-isomer and Cardiac Toxicity

ArticleYear
Dapagliflozin protects against doxorubicin-induced cardiotoxicity by restoring STAT3.
    Archives of toxicology, 2022, Volume: 96, Issue:7

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzhydryl Compounds; Cardiotoxicity; Doxorubicin; Glucosides; Humans; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; STAT3 Transcription Factor

2022
Ononin alleviates endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity by activating SIRT3.
    Toxicology and applied pharmacology, 2022, 10-01, Volume: 452

    Topics: Animals; Apoptosis; Cardiotoxicity; Doxorubicin; Endoplasmic Reticulum Stress; Glucosides; Isoflavones; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Sirtuin 3; Stroke Volume; Ventricular Function, Left

2022
Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation.
    International journal of molecular sciences, 2022, Sep-04, Volume: 23, Issue:17

    Topics: Animals; Apoptosis; Benzhydryl Compounds; Cardiotoxicity; Doxorubicin; Fibrosis; Glucosides; Hypertrophy; Inflammation; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Ventricular Remodeling

2022
Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
    Cardiovascular diabetology, 2020, 05-15, Volume: 19, Issue:1

    Topics: Animals; Benzhydryl Compounds; Cardiomyopathies; Cardiotoxicity; Diastole; Disease Models, Animal; Doxorubicin; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Glucosides; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Sodium-Glucose Transporter 2 Inhibitors; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2020
Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway.
    Journal of cardiovascular translational research, 2021, Volume: 14, Issue:2

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Cardiotoxicity; Cell Line; Disease Models, Animal; Doxorubicin; Forkhead Box Protein O1; Glucosides; Heart Diseases; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Nerve Tissue Proteins; Oxidative Stress; Phenols; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA-Binding Proteins; Signal Transduction; Ventricular Function, Left

2021
NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells.
    International journal of molecular sciences, 2020, Oct-21, Volume: 21, Issue:20

    Topics: Antineoplastic Agents, Immunological; Benzhydryl Compounds; Biomarkers, Pharmacological; Cardiotoxicity; Cell Line, Tumor; CTLA-4 Antigen; Female; Glucose; Glucosides; Humans; Hyperglycemia; Ipilimumab; Leukotriene B4; Myeloid Differentiation Factor 88; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Sodium-Glucose Transporter 2 Inhibitors; Transcription Factor RelA; Triple Negative Breast Neoplasms

2020
Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients.
    Archives of toxicology, 2021, Volume: 95, Issue:2

    Topics: Adolescent; Adult; Aged; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzhydryl Compounds; Breast Neoplasms; Cardiotoxicity; Caspase 3; Cell Line; Cell Survival; Comorbidity; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Doxorubicin; Echocardiography; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Female; Glucosides; Humans; Male; Middle Aged; Myocytes, Cardiac; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retrospective Studies; Young Adult

2021
Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways.
    Cardiovascular toxicology, 2021, Volume: 21, Issue:9

    Topics: Action Potentials; Animals; Benzhydryl Compounds; Cardiotoxicity; Cell Proliferation; Disease Models, Animal; Doxorubicin; Glucosides; Heart Diseases; Heart Rate; Male; Mitochondria, Heart; Myocytes, Cardiac; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Ventricular Function, Left

2021
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
    Cardiovascular diabetology, 2021, 07-23, Volume: 20, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Antifibrotic Agents; Apoptosis; Benzhydryl Compounds; Cardiotoxicity; Cell Line; Cytokines; Disease Models, Animal; Doxorubicin; Female; Ferroptosis; Fibrosis; Glucosides; Heart Diseases; Inflammasomes; Inflammation Mediators; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Function, Left

2021
Cardioprotective effects of corilagin on doxorubicin induced cardiotoxicity via P13K/Akt and NF-κB signaling pathways in a rat model.
    Toxicology mechanisms and methods, 2022, Volume: 32, Issue:2

    Topics: Animals; Apoptosis; Cardiotoxicity; Doxorubicin; Glucosides; Hydrolyzable Tannins; NF-kappa B; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction

2022
Dietary cyanidin 3-glucoside from purple corn ameliorates doxorubicin-induced cardiotoxicity in mice.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2017, Volume: 27, Issue:5

    Topics: Animal Feed; Animals; Anthocyanins; Cardiotoxicity; Cell Survival; Cytoprotection; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Female; Gene Expression Regulation; Glucosides; Heart Diseases; HeLa Cells; Humans; MCF-7 Cells; Mice, Inbred C57BL; Myocytes, Cardiac; Phytotherapy; Plant Extracts; Plants, Medicinal; Protective Agents; Time Factors; Zea mays

2017
Synergistic effects of polydatin and vitamin C in inhibiting cardiotoxicity induced by doxorubicin in rats.
    Fundamental & clinical pharmacology, 2017, Volume: 31, Issue:3

    Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Arterial Pressure; Ascorbic Acid; Cardiotoxicity; Doxorubicin; Drug Synergism; Glucosides; Glutathione; Glutathione Peroxidase; Heart Rate; Male; Malondialdehyde; Myocardium; Oxidative Stress; PPAR gamma; Rats; Rats, Sprague-Dawley; Stilbenes; Superoxide Dismutase

2017